Hints and tips:
Showing results for Sherri M. Roche
Related Special Reports
...Miels said the company intends to do as much global M&A in 2024 as it did this year....
...Roche is therefore acquiring US-based obesity drugs developer Carmot for up to $3.1bn. The Swiss company already has a packed pipeline. The problem is that too many drug trials have failed....
...The winners will, again, be M&A bankers. Pharma companies, while talking up pipelines, are turning to deals to boost their growth outlook....
...“I’m a shareholder too, and I don’t want that.”...
...JPMorgan has named Alex Bruce as head of Emea M&A for its financial sponsors group, and tapped Nitin Maheshwari as head of Asia-Pacific strategic investors group M&A....
...“I hope to get it done before I’m 65.” Celeste Roche, 41, one of the few attendees not already convinced about reunification, left the conference in pensive mood....
...Roche and AstraZeneca have already struck deals to buy or license early stage weight-loss drugs....
...It’s owned by art collector Maja Hoffmann — as in Hoffmann-La Roche, of Roche Pharmaceuticals — who is investing some of the family’s wealth in the region where she grew up....
...So I think I’m a great S&P 500 tracker fund guy....
...His total pay package at Roche, which he has led since 2008, was SFr11mn in 2020....
...Results: Banco Santander FY, Boeing Q4, Chubb Q4, Fujitsu Q3, GSK Q4, H&M FY, Hitachi Q3, Mastercard Q4, Match Group Q4, Nasdaq Q4, Nomura Holdings Q3, Novartis Q4, Novo Nordisk Q4, Qualcomm Q1, Samsung...
...As for me, I’m keen to enjoy the journey this year, rather than only the destination. Emma Jacobs is an FT features writer...
...The Energy Source newsletter (for Premium subscribers) details five trends likely to dominate the sector this year, from oil prices and M&A to renewables, reshoring and US dominance in liquefied natural...
...Stefan Oelrich, head of pharma, has embarked on an M&A spree over the past few years to offset the patent cliff, forking out billions of euros on companies that specialise in cell and gene therapy....
...In other deal news: Roche announced earlier today that it is planning to buy immunology company Telavant from Roivant Sciences and Pfizer for more than $7bn. 2....
...At Roche, it freed up some $3bn a year that could be spent on innovation....
...Instead of mere rooms, there’ll be “personal havens” with a minimum area of 40 sq m, making them some of the largest in the city....
...Now, a new wave of M&A is set to make those industry giants even bigger. Bring on the Mega Majors. (DD is currently accepting submissions for a better buzzword.)...
...I’m collecting images of customers who match our pastels.” “Sure,” says the tourist and bows her head next to the “Aubergine” range, a box of purples....
...But I’m going against the grain....
...I have basically been living in hotels for the past 15 years or so of my life, but now I’m, like: “OK, it’s time to settle.”...
...“Supping with the devil” is the phrase used by Hoffmann, who marries his time rewilding with the vice-chair of his family’s drug company, Roche. His response?...
...I’m heading to the Dolomites for a week in early August and plan to get in as many miles as my legs will endure. I’m no moutaineer, but I like a long walk....
...All it needs is M A D R I D underneath to complete the look. ¡Que chique! Group 5: Abstract or uncategorisable . . . and the rest....
...Jefferies banker Jeffrey Altman has joined JLL’s M&A team as a senior managing director, based in New York....
International Edition